Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Elections Post Observer.
Press releases published on June 9, 2025

NIH Staff Demand NIH and HHS Leadership Uphold NIH Mission in “Bethesda Declaration”
The Bethesda Declaration raises concern over pressure to implement measures that harm the public. WASHINGTON, DC, UNITED STATES, June 9, 2025 /EINPresswire.com/ -- Federal employees at the National Institutes of Health (NIH) have stood up for the health …

Fathers: The Spiritual Backbone of America Eden Gordon Media & Great American Media Celebrates Dads Leading with Faith
Fathers: The Spiritual Backbone of America –Eden Gordon Media …

🇨🇦 Now launched: G7 Canada – The Kananaskis Summit
Resilient Leadership in Uncertain Times LONDON, UNITED KINGDOM, June 9, 2025 /EINPresswire.com/ -- Resilient leadership in uncertain times – G7 Canada: The Kananaskis Summit explores the next phase of collective action • With Canada as host, G7 …

Oddity Finance LLC Announces Proposed $350 Million Offering of 0% Exchangeable Senior Notes Due 2030
As of March 31, 2025, ODDITY had $257 million in cash, and an undrawn $200 million credit line Capital raise gives ODDITY additional firepower to play offense and pursue future opportunities in a volatile world A portion of the proceeds will be used to …

AB Science announces EMA approval of Masivet shelf-life extension to 4 years
PRESS RELEASE AB SCIENCE ANNOUNCES EMA APPROVAL OF MASIVET® SHELF-LIFE EXTENSION TO 4 YEARS Paris, June 9, 2025, 8am CET AB Science SA (Euronext - FR0010557264 - AB) today announced that the European Medicine Agency (EMA) has approved the extension of the …

AB Science annonce l’approbation par l’EMA de la prolongation de la durée de conservation de Masivet à 4 ans
COMMUNIQUE DE PRESSE AB SCIENCE ANNONCE L'APPROBATION PAR L'EMA DE LA PROLONGATION DE LA DURÉE DE CONSERVATION DE MASIVET® À 4 ANS Paris, 9 juin 2025, 8h AB Science SA (Euronext - FR0010557264 - AB) annonce aujourd'hui que l'Agence européenne des …

UPDATE ON THE TERMS OF THE SHAREHOLDERS GENERAL MEETING
UPDATE ON THE TERMS OF THE SHAREHOLDERS GENERAL MEETING Nantes, June 9th, 2025, 8 a.m. - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) informs its shareholders and the market of the update on the terms of the Combined General Meeting scheduled …

Shell Plc First Quarter 2025 Euro and GBP Equivalent Dividend Payments
SHELL PLC FIRST QUARTER 2025 EURO AND GBP EQUIVALENT DIVIDEND PAYMENTS June 9, 2025 The Board of Shell plc today announced the pounds sterling and euro equivalent dividend payments in respect of the first quarter 2025 interim dividend, which was announced …

MISE À JOUR DES MODALITÉS DE L’ASSEMBLÉE GÉNÉRALE
MISE À JOUR DES MODALITÉS DE L’ASSEMBLÉE GÉNÉRALE Nantes, France, 9 juin 2025, 8 heures – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), informe ses actionnaires et le marché de la mise à jour des modalités de l’Assemblée Générale Mixte …

Press Release: Sanofi accelerates global shipping of Beyfortus to prepare healthcare providers months ahead of 2025-2026 RSV season
Sanofi accelerates global shipping of Beyfortus to prepare healthcare providers months ahead of 2025-2026 RSV season Paris, June 9, 2025. Sanofi is shipping Beyfortus (nirsevimab) starting in early Q3 to ensure broad availability well ahead of the 2025- …

Communiqué de presse : Sanofi accélère la livraison mondiale de Beyfortus pour préparer les professionnels de santé plusieurs mois avant la saison 2025-2026 de VRS
Sanofi accélère la livraison mondiale de Beyfortus pour préparer les professionnels de santé plusieurs mois avant la saison 2025-2026 de VRS Paris, le 9 juin 2025. Sanofi livrera Beyfortus (nirsevimab) dès le début du T3 pour assurer une large …